Xin-Peng Li (Xinpeng Li)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 6

Top Topics

Signaling Pathway

Diabetic Nephropathy

Pulmonary Fibrosis

Silver Nanoparticles

Top Venues

Oxidative medicine and cellular longevity

Journal of diabetes research

International journal of analytical chemistry

Phytotherapy research : PTR

IOCAS (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

IOCAS

China

PHD

Publications

Ping Sun, Xin-Peng Li, Jie Xin, Tao Xue, Bo Zhang, Yan-Juan Liu
Development of a Colloidal Gold Immunochromatographic Strip for the One-Step Evaluation of the Total Content of Rhein and Aloe-Emodin in Rhubarb. International journal of analytical chemistry 2022 (2022)
Bo Zhang, Yanli Yuan, Jie Xin, Min Chen, Zhen Wang, Xin-Peng Li, Tao Xue
Study of Water- and Organic-Soluble Extracts from Trichosanthes on Type 1 Diabetes Mellitus. Journal of diabetes research 2022 (2022)
Huidan Dong, Tao Xue, Yanjuan Liu, Shan He, Yanliang Yi, Bo Zhang, Jie Xin, Zhen Wang, Xin-Peng Li
Low Molecular Weight Fucoidan Inhibits Pulmonary Fibrosis In Vivo and In Vitro via Antioxidant Activity. Oxidative medicine and cellular longevity 2022 (2022)
Yueshang Wang, Xin-Peng Li, Shiwen Pu, Xiao Wang, Lan-Ping Guo, Lisheng Zhang, Zhen Wang
Ameliorative Effects of Arctigenin on Pulmonary Fibrosis Induced by Bleomycin via the Antioxidant Activity. Oxidative medicine and cellular longevity 2022 (2022)
Yan Wang, Yanlei Sun, Fengli Shao, Bo Zhang, Zhen Wang, Xin-Peng Li
Low Molecular Weight Fucoidan Can Inhibit the Fibrosis of Diabetic Kidneys by Regulating the Kidney Lipid Metabolism. Journal of diabetes research 2021 (2021)
Jingge Xu, Yan Wang, Zhen Wang, Lanping Guo, Xin-Peng Li
Fucoidan mitigated diabetic nephropathy through the downregulation of PKC and modulation of NF-κB signaling pathway: in vitro and in vivo investigations. Phytotherapy research : PTR 35 (4) (2020)